Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.5373
-0.0538-9.10%
Post-market: 0.54680.0095+1.77%18:33 EDT
Volume:391.17K
Turnover:219.20K
Market Cap:49.31M
PE:-0.36
High:0.5900
Open:0.5804
Low:0.5370
Close:0.5911
Loading ...

Verrica to preset results on VP-315 at Fall Clinical Dermatology Conference

TIPRANKS
·
24 Oct 2024

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of Vp-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

THOMSON REUTERS
·
24 Oct 2024

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

GlobeNewswire
·
24 Oct 2024

Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...

GuruFocus.com
·
10 Oct 2024

BRIEF-Verrica Pharmaceuticals Says As Result Of Craig Ballaron's Resignation, Co Temporarily Not In Compliance With Nasdaq Listing Requirements

Reuters
·
09 Oct 2024

Verrica Pharmaceuticals Inc: as a Result of Craig Ballaron's Resignation, Co Temporarily Not in Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
09 Oct 2024

Optinose names Terry Kohler as CFO

TIPRANKS
·
08 Oct 2024

RBC Lowers Price Target on Verrica Pharmaceuticals to $11 From $13, Keeps Outperform, Speculative Risk

MT Newswires Live
·
04 Oct 2024

The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%

Simply Wall St.
·
03 Oct 2024

Needham Downgrades Verrica Pharmaceuticals to Hold From Buy

MT Newswires Live
·
03 Oct 2024

Needham downgrades Verrica Pharmaceuticals (VRCA) to a Hold

TIPRANKS
·
03 Oct 2024

Verrica Pharmaceuticals Cut to Hold From Buy by Brookline Capital

Dow Jones
·
03 Oct 2024

Verrica Pharmaceuticals to Restructure Sales, Operating Teams; Cut Sales Territories

MT Newswires Live
·
02 Oct 2024

Verrica Pharmaceuticals Inc - Restructuring Expected to Reduce Cost Structure by Approximately 50%

THOMSON REUTERS
·
02 Oct 2024

Verrica Pharmaceuticals Inc - One-Time Restructuring Charge of Approximately $1 Million

THOMSON REUTERS
·
02 Oct 2024

Verrica Pharmaceuticals Inc - Headcount in Certain Support Functions to Be Reduced

THOMSON REUTERS
·
02 Oct 2024